DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Increased inflammation in sanctuary sites may explain viral blips in HIV infection

Abstract

Here, combined antiretroviral therapy (cART) suppress HIV-1 viral replication, such that viral load in plasma remains below the limit of detection in standard assays. However, intermittent episodes of transient viremia (blips) occur in a set of HIV-patients. Given that follicular hyperplasia occurs during lymphoid inflammation as a normal response to infection, it is hypothesised that when the diameter of the lymph node follicle (LNF) increases and crosses a critical size, a viral blip occurs due to cryptic viremia. To study this hypothesis, a theoretical analysis of a mathematical model is performed to find the conditions for virus suppression in all compartments and different scenarios of LNF size changes are simulated. According to the analysis, blips with duration of around 30 days arise when the diameter rise rate is between 0.02 and 0.03 days–1. Moreover, the final diameter of the site is directly related to the steady states of the virus load after the occurrence of a blip. When the value of R0 is around 2.1, to have a steady-state below the limit of detection after the viral blip, the maximum final diameters should be greater than 0.7 mm so that there is a relative loss of connection between compartments.

Authors:
 [1];  [2];  [3]
  1. Pennsylvania State Univ., Malvern, PA (United States)
  2. Los Alamos National Lab. (LANL), Los Alamos, NM (United States); Univ. of Delaware, Newark, DE (United States)
  3. Univ. of Delaware, Newark, DE (United States)
Publication Date:
Research Org.:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1255268
Report Number(s):
LA-UR-16-20164
Journal ID: ISSN 1751-8849
Grant/Contract Number:  
AC52-06NA25396
Resource Type:
Accepted Manuscript
Journal Name:
IET Systems Biology
Additional Journal Information:
Journal Name: IET Systems Biology; Journal ID: ISSN 1751-8849
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; Biological Science

Citation Formats

Piovoso, Michael J., Cardozo, E. Fabian, and Zurakowski, Ryan. Increased inflammation in sanctuary sites may explain viral blips in HIV infection. United States: N. p., 2016. Web. doi:10.1049/iet-syb.2015.0066.
Piovoso, Michael J., Cardozo, E. Fabian, & Zurakowski, Ryan. Increased inflammation in sanctuary sites may explain viral blips in HIV infection. United States. https://doi.org/10.1049/iet-syb.2015.0066
Piovoso, Michael J., Cardozo, E. Fabian, and Zurakowski, Ryan. Mon . "Increased inflammation in sanctuary sites may explain viral blips in HIV infection". United States. https://doi.org/10.1049/iet-syb.2015.0066. https://www.osti.gov/servlets/purl/1255268.
@article{osti_1255268,
title = {Increased inflammation in sanctuary sites may explain viral blips in HIV infection},
author = {Piovoso, Michael J. and Cardozo, E. Fabian and Zurakowski, Ryan},
abstractNote = {Here, combined antiretroviral therapy (cART) suppress HIV-1 viral replication, such that viral load in plasma remains below the limit of detection in standard assays. However, intermittent episodes of transient viremia (blips) occur in a set of HIV-patients. Given that follicular hyperplasia occurs during lymphoid inflammation as a normal response to infection, it is hypothesised that when the diameter of the lymph node follicle (LNF) increases and crosses a critical size, a viral blip occurs due to cryptic viremia. To study this hypothesis, a theoretical analysis of a mathematical model is performed to find the conditions for virus suppression in all compartments and different scenarios of LNF size changes are simulated. According to the analysis, blips with duration of around 30 days arise when the diameter rise rate is between 0.02 and 0.03 days–1. Moreover, the final diameter of the site is directly related to the steady states of the virus load after the occurrence of a blip. When the value of R0 is around 2.1, to have a steady-state below the limit of detection after the viral blip, the maximum final diameters should be greater than 0.7 mm so that there is a relative loss of connection between compartments.},
doi = {10.1049/iet-syb.2015.0066},
journal = {IET Systems Biology},
number = ,
volume = ,
place = {United States},
year = {Mon Aug 01 00:00:00 EDT 2016},
month = {Mon Aug 01 00:00:00 EDT 2016}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 2 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

A Stochastic Model of Latently Infected Cell Reactivation and Viral Blip Generation in Treated HIV Patients
journal, April 2011


Follicular B helper T cells in antibody responses and autoimmunity
journal, November 2005

  • Vinuesa, Carola G.; Tangye, Stuart G.; Moser, Bernhard
  • Nature Reviews Immunology, Vol. 5, Issue 11
  • DOI: 10.1038/nri1714

Proliferating Active Cells, Lymphocyte Subsets, and Dendritic Cells in Recurrent Tonsillitis: Their Effect on Hypertrophy
journal, May 2008


Blood Microcirculation in the Lymph node During the Primary Immune Response
journal, October 1972

  • Herman, Peter G.; Yamamoto, Itaru; Mellins, Harry Z.
  • Journal of Experimental Medicine, Vol. 136, Issue 4
  • DOI: 10.1084/jem.136.4.697

Intermittent HIV-1 Viremia (Blips) and Drug Resistance in Patients Receiving HAART
journal, February 2005


Deep Molecular Characterization of HIV-1 Dynamics under Suppressive HAART
journal, October 2011


Viral Blips May Not Need a Trigger: How Transient Viremia Can Arise in Deterministic In-Host Models
journal, January 2014

  • Zhang, Wenjing; Wahl, Lindi M.; Yu, Pei
  • SIAM Review, Vol. 56, Issue 1
  • DOI: 10.1137/130937421

Tracking episomal HIV DNA: implications for viral persistence and eradication of HIV
journal, January 2013


Magnitude of Virologic Blips Is Associated With a Higher Risk for Virologic Rebound in HIV-Infected Individuals: A Recurrent Events Analysis
journal, April 2012

  • Grennan, J. Troy; Loutfy, Mona R.; Su, DeSheng
  • The Journal of Infectious Diseases, Vol. 205, Issue 8
  • DOI: 10.1093/infdis/jis104

Increase in 2–Long Terminal Repeat Circles and Decrease in D-dimer After Raltegravir Intensification in Patients With Treated HIV Infection: A Randomized, Placebo-Controlled Trial
journal, August 2013

  • Hatano, Hiroyu; Strain, Matthew C.; Scherzer, Rebecca
  • The Journal of Infectious Diseases, Vol. 208, Issue 9
  • DOI: 10.1093/infdis/jit453

Lymphoid Fibrosis Occurs in Long-Term Nonprogressors and Persists With Antiretroviral Therapy but May Be Reversible With Curative Interventions
journal, October 2014

  • Sanchez, Joyce L.; Hunt, Peter W.; Reilly, Cavan S.
  • Journal of Infectious Diseases, Vol. 211, Issue 7
  • DOI: 10.1093/infdis/jiu586

Florid Reactive Follicular Hyperplasia in Elderly Patients. A Clinicopathological Study of 23 Cases
journal, January 1998


The paradox of the immune response in HIV infection: When inflammation becomes harmful
journal, February 2013


Excitability in the host–pathogen interactions of HIV infection and emergence of viral load blips
journal, January 2013

  • Nkoa Onana, Denis Fils; Mewoli, Boulchard; Ouattara, Djomangan Adama
  • Journal of Theoretical Biology, Vol. 317
  • DOI: 10.1016/j.jtbi.2012.10.018

Modeling HIV persistence, the latent reservoir, and viral blips
journal, September 2009


Lymphoid tissue viral burden and duration of viral suppression in plasma
journal, January 2001


Transient Viremia, Plasma Viral Load, and Reservoir Replenishment in HIV-Infected Patients on Antiretroviral Therapy
journal, January 2007

  • Jones, Laura E.; Perelson, Alan S.
  • JAIDS Journal of Acquired Immune Deficiency Syndromes, Vol. 45, Issue 5
  • DOI: 10.1097/QAI.0b013e3180654836

Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy
journal, September 2005

  • Popovic, M.; Tenner-Racz, K.; Pelser, C.
  • Proceedings of the National Academy of Sciences, Vol. 102, Issue 41
  • DOI: 10.1073/pnas.0506857102

Viral Blip Dynamics during Highly Active Antiretroviral Therapy
journal, November 2003


Influence of Episodes of Intermittent Viremia (“Blips”) on Immune Responses and Viral Load Rebound in Successfully Treated HIV-Infected Patients
journal, January 2013

  • Castro, Pedro; Plana, Montserrat; González, Raquel
  • AIDS Research and Human Retroviruses, Vol. 29, Issue 1
  • DOI: 10.1089/aid.2012.0145

HIV-1 intermittent viraemia in patients treated by non-nucleoside reverse transcriptase inhibitor-based regimen
journal, January 2005


Immunoarchitecture of lymphoid tissue in HIV-infection during antiretroviral therapy correlates with viral persistence
journal, September 2004


Residual Viremia Is Preceding Viral Blips and Persistent Low-Level Viremia in Treated HIV-1 Patients
journal, October 2014


Redefining the Viral Reservoirs that Prevent HIV-1 Eradication
journal, September 2012


Factors associated with collagen deposition in lymphoid tissue in long-term treated HIV-infected patients
journal, January 2010


Persistence of HIV-1 resistance in lymph node mononuclear cell RNA despite effective HAART
journal, January 2001


No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1–Infected Patients Receiving Antiretroviral Therapy
journal, January 2012

  • Gandhi, Rajesh T.; Coombs, Robert W.; Chan, Ellen S.
  • JAIDS Journal of Acquired Immune Deficiency Syndromes, Vol. 59, Issue 3
  • DOI: 10.1097/QAI.0b013e31823fd1f2

Tissue Says Blood Is Misleading, Confusing HIV Cure Efforts
journal, December 2011


HIV Model Parameter Estimates from Interruption Trial Data including Drug Efficacy and Reservoir Dynamics
journal, July 2012


Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues
journal, January 2014

  • Fletcher, Courtney V.; Staskus, Kathryn; Wietgrefe, Stephen W.
  • Proceedings of the National Academy of Sciences, Vol. 111, Issue 6
  • DOI: 10.1073/pnas.1318249111

HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
journal, March 2010

  • J. Buzón, Maria; Massanella, Marta; Llibre, Josep M.
  • Nature Medicine, Vol. 16, Issue 4
  • DOI: 10.1038/nm.2111

Benign lymphadenopathies
journal, January 2013


Short Communication: HIV Blips While on Antiretroviral Therapy Can Indicate Consistently Detectable Viral Levels Due to Assay Underreporting
journal, December 2013

  • Murray, John M.; Zaunders, John J.; Koelsch, Kersten K.
  • AIDS Research and Human Retroviruses, Vol. 29, Issue 12
  • DOI: 10.1089/aid.2013.0132

Discrepancies between Protease Inhibitor Concentrations and Viral Load in Reservoirs and Sanctuary Sites in Human Immunodeficiency Virus-Infected Patients
journal, January 2003

  • Solas, Caroline; Lafeuillade, Alain; Halfon, Philippe
  • Antimicrobial Agents and Chemotherapy, Vol. 47, Issue 1
  • DOI: 10.1128/AAC.47.1.238-243.2003

Modelling HIV-1 2-LTR dynamics following raltegravir intensification
journal, July 2013

  • Luo, Rutao; Cardozo, E. Fabian; Piovoso, Michael J.
  • Journal of The Royal Society Interface, Vol. 10, Issue 84
  • DOI: 10.1098/rsif.2013.0186

Viral Blip Dynamics during Highly Active Antiretroviral Therapy
journal, November 2003


Persistence of HIV-1 resistance in lymph node mononuclear cell RNA despite effective HAART
journal, January 2001


Discrepancies between Protease Inhibitor Concentrations and Viral Load in Reservoirs and Sanctuary Sites in Human Immunodeficiency Virus-Infected Patients
journal, January 2003


Lymphoid tissue viral burden and duration of viral suppression in plasma
journal, January 2001


Spatial modeling of HIV cryptic viremia and 2-LTR formation during raltegravir intensification
journal, March 2014


Works referencing / citing this record:

Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence
journal, January 2018

  • Martinez-Picado, Javier; Zurakowski, Ryan; Buzón, María José
  • Retrovirology, Vol. 15, Issue 1
  • DOI: 10.1186/s12977-018-0398-1

Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence
journal, January 2018

  • Martinez-Picado, Javier; Zurakowski, Ryan; Buzón, María José
  • Retrovirology, Vol. 15, Issue 1
  • DOI: 10.1186/s12977-018-0398-1